Defence Therapeutics Inc. (CSE:DTC)
Canada · Delayed Price · Currency is CAD 0.6100
+0.0100 (1.67%)
At close: Feb 27, 2026
Defence Therapeutics Market Cap
Defence Therapeutics has a market cap or net worth of CAD 35 million as of March 2, 2026. Its market cap has decreased by -39.15% in one year.
Market Cap
35.00M
Enterprise Value
35.54M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.61
Market Cap Chart
Since May 7, 2021, Defence Therapeutics's market cap has decreased from 89.08M to 35.00M, a decrease of -60.72%. That is a compound annual growth rate of -17.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 35.00M | -15.28% |
| Dec 31, 2025 | 41.31M | 31.21% |
| Dec 31, 2024 | 31.48M | -69.62% |
| Dec 29, 2023 | 103.61M | 5.29% |
| Dec 30, 2022 | 98.41M | -49.44% |
| Dec 31, 2021 | 194.63M | 118.48% |
| May 7, 2021 | 89.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 62.62M |
| MedMira | 48.82M |
| Sernova Biotherapeutics | 47.47M |
| Devonian Health Group | 38.03M |
| BriaCell Therapeutics | 37.78M |
| Resverlogix | 34.73M |
| Microbix Biosystems | 33.25M |
| Telescope Innovations | 28.69M |